Familial hypercholesterolaemia trials in Japan
3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
- Where
- Kakegawa
- Age
- 6 years to 17 years
- People
- 153 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07058077 · EU 2024-519068-42-00 - No phaseTaking peopleGuideline Oriented Approach To Lipid Lowering In Asia-Pacific
- Where
- Fukuoka, Mitaka, Osaka
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Stephen Nicholls
See details and how to joinNCT05325034 - Phase 4Taking peopleA Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
- Where
- Hokkaido, Ibaraki, Kagawa, Kanagawa, Osaka, Saitama, Tokyo
- Age
- 18 years and over
- People
- 120
- Run by
- Kowa Company, Ltd.
See details and how to joinNCT07634484